WHO Mental Health Gap Action Program (mhGAP) for Improving Child Mental and Behavioral Disorder Service Quality in China

Condition(s) studied

Investigational drug(s) / intervention(s)

mental health gap action program intervention guide (mhGAP-IG): The mhGAP-IG is an evidence-based intervention developed by WHO. It was designed for non-specialists to scale up high quality mental health services. Although more than 90 countries worldwide have implemented mhGAP-IG, this study is the first to evaluated if it works for scaling up CMBDs services in China. Investigators have cultrually adapted the mhGAP-IG according Chinese context.

Study summary

The goal of this clinical trial is to learn if the adapted mhGAP intervention guide (mhGAP-IG) can improve quality of child mental and behavioral disorders (CMBDs) services in China. It will also learn about the implementation of the mhGAP-IG delivered by kindergarten teachers. The main questions it aims to answer are:

* Does the adapted mhGAP-IG reduce the symptom severity among children with CMBDs between two and sis years old?
* Does the adapted mhGAP-IG reduce psychological distress among caregivers of children with CMBDs?
* Does the adapted mhGAP-IG improve mental and behavioral health serivces capacity among kindergarten teachers in China?
* How is the feasibility, acceptablity, and what are barriers and facilitators of implementation?

Researchers will compare the adapted mhGAP-IG to child healthcare as usual to see if the adapted mhGAP-IG can improve quality of child mental and behavioral disorders services in China.

Participants (kindergarten teachers) will:

* Complete questionnaires and scales at baseline and at 3-, 6-, 9- and 12- months of intervention;
* Receive mhGAP-based trainings;
* Deliver long-term child mental and behavioral disorders services (including screenings, referals, follow-up, and physcosocial interventions) to children with CMBDs.

Participants (children/caregivers) will:

* Complete questionnaires and scales at baseline and at 3-, 6- and 12- months of intervention.
* Accept long-term CMBDs management (including screenings, referals, follow-up management, and physcosocial interventions) from mhGAP-trained kindergarten teachers.

Eligibility

Primary outcome measure(s)

• Symptom severity of CMBDs assessed by Strengths and Difficulties Questionnaire (SDQ) — baseline and 3-, 6- and 12- months of intervention
  A total score ranges from 0 (lowest distress) to 60 (highest distress) and higher scores of SDQ indicate the worse symptom.
• Developmental domain scores measured by Ages and Stages Questionnaire (ASQ) — baseline and 3-, 6- and 12- months of intervention
  Developmental domain scores derived from ASQ. The ASQ consists of a series of questionnaires specifically designed for children at different months of age. The total score range varies depending on the questionnaire for each age group, but higher scores consistently indicate better development within a particular domain.

Trial sites (9)

More Sun Yat-sen University trials in China

Other trials for the same condition